Databases to cells to genotypes to metabolites.Eicosanoid signaling precursors are determined by an

来源 :2017精准健康和精准营养国际研讨会 | 被引量 : 0次 | 上传用户:nuclear01
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The widespread availability of high throughput methods have enabled rapid advances in establishing associations between single nucleotide polymorphisms and health outcomes.Commonly used SNPs were generally chosen to track heritage blocks not connected to causing differences in genetic function via GWAS.Diversity in gene function extends beyond SNPs to other genetic elements including insertion-deletions(Indels).Endogenous PUFA levels are regulated by diet PUFA.The fatty acid desaturase(FADS)gene cluster has been identified in dozens of GWAS as associated with health and biochemical outcomes.We sought to identify causal variants that control FADS expression and PUFA levels.First computationally we searched the International Hapmap Project database in Japanese participants for expression quantitative trait locus(eQTL)and identified a highly significant region in intron 1 of FADS2 associated with lower expression of FADS1 in the minor allele,and identified predicted consensus biding site for two transcription factors,PPARg and SREBP,and hypothesized that polymorphisms nearby would affect binding.Second lymphoblasts homozygous for the major and minor alleles were cultured leading to the discovery that FADS1 expression is lower in the minor vs major haplotype,and that expression of both FADS1 and FADS2 was strongly modulated by SREBP but not PPARg binding drugs.We sequenced and discovered a 22 bp Indel 137 bp from the SRE: the minor allele is a deletion and the major allele an insertion.Returning to computation with the 1000 genome database we showed that the Indel status causes positive selection related to ancestral diet.Third we compared Indel genotype (rs66698963)from 199 individuals in Kansas City and 1,500 in Beijing against the circulating PUFA and find that circulating arachidonic acid and all omega-3 PUFA are determined genotype.Taken together,these data strongly support rs66698963 Indel as a causal locus in determining arachidonic acid status,with broad implications for inflammation,thrombosis,and related metabolic risk factors.We suggest that genotype at this locus should be considered in all studies of LCPUFA interventions
其他文献
临床药师对1例多部位MRSA感染患者出院后抗菌药物口服序贯方案进行分析,指出临床工作中,对于MRSA引起的多部位严重感染,一定要保证抗生素的疗程,以降低感染复发风险,在患者症状好转和细菌负荷量减少的情况下,可考虑改为口服抗生素治疗。口服方案可以选择以利福平为基础,联合其他敏感抗生素,另一抗生素的选择往往需要药师结合药敏结果、组织分布及患者对药物的耐受性等综合考虑个体化的给药方案,并对患者用药安全性
目的:制定福建省某三级甲等医院耳鼻喉科抗菌药物应用控制指标,以期为某院耳鼻喉科抗菌药物的合理应用和科学管理提供参考依据.方法:借助Medline、Embase、PubMed、The CochraneLibrary、CNKI、VIP、WanFang Data数据库,检索抗菌药物相关的指南、专家共识、随机对照试验或meta分析、抗菌药物法规文件,结合某院耳鼻喉科疾病分布特点,制定某院耳鼻喉科抗菌药物临
目的:对本院多西紫杉醇相关不良反应的特点及其影响因素进行分析,为临床合理用药及个体化给药提出建议.方法:通过医院信息系统(HIS)导出本院2014年4月—2015年4月所有使用多西紫杉醇进行抗肿瘤化疗患者的病历共362份,从中调取多西紫杉醇相关不良反应报告91份,通过回顾性分类统计对不良反应报告进行综合分析.结果:362份病例中,有91份多西紫杉醇相关不良反应报告,其中50-69岁年龄段的患者有5
目的:建立中国帕金森病患者人群普拉克索群体药动学模型.方法:前瞻性收集服用普拉克索的帕金森病(PD)门诊患者稳态谷浓度109例162个血样,超高效液相色谱-质谱联用法(UPLC-MS/MS)法测定普拉克索血药浓度.应用NONMEM软件进行群体药动学数据分析.结果:数据采用一房室模型拟合,肾小球滤过率(GFR)对普拉克索清除率有显著影响,性别(sex)、体质量(WT)、给药剂量(TAMT)、合并用药
瑞舒伐他汀作为一款被广泛使用的降低人体低密度脂蛋白胆固醇以及预防心血管疾病的药物。在长期使用的过程中应当合理用药,尽可能的削弱其发生副作用的风险。经研究表明瑞舒伐他汀在体内主要以原型药物形式排除,仅有药物通过肝脏CYP酶代谢。因此,参与瑞舒伐他汀在体内吸收,分布,转运和排泄的数种蛋白转运体的活性以及对瑞舒伐他汀亲和力的变化将会直接影响该药物在人体内的利用率以及个体化差异。其中,在瑞舒伐他汀代谢过程
目的:探讨MDR1C3435T基因多态性对华法林优映体(S-华法林)及劣映体(R-华法林)血药浓度及优劣比和疗效的影响.方法:以UPLC-MS/MS法检测患者用药后R-华法林及S-华法林的稳态谷浓度,以PCR-RFLP法鉴定患者MDR1C3435T基因型,并监测INR值.将测得的基因型分布用Hardy-Weinberg遗传平衡检验群体代表性,用SPSS13.0软件以QQ-plot法检验INR值及R
目的:了解厦门市第三医院(简称“本院”)2014年药品不良反应(ADR)报告的特点,为加强ADR监测和促进临床合理用药提供参考.方法:收集本院2014年的559例ADR报告,对报告总数、患者性别与年龄、涉及药品基本情况、ADR基本情况、报告人职业及科室分布等进行统计分析.结果:医院加强行政干预、宣传教育,ADR年度报告总数连年递增;男女之比为1.18∶1,15-44岁占46.15%,最为突出;55
Results from clinical trials and food fortification initiatives demonstrate that most neural tube defects(NTDs)can be prevented by maternal folic acid intake.Other studies have shown relationships amo
会议
One fundamental principle of biology is interaction,understanding of which forms the basis for the development of novel therapeutic and preventive strategies with proven clinical efficacy(Phase Ⅲ)and
会议
The traditional way to define a physiological or pathological state is to measure a set of molecules/nodes concentrations.Here,we developed an edge-based workflow to integrate multi-omics data and con
会议